WAVE LIFE SCIENCES LTD
WVENASDAQ🏆 #1805 by market capUS Equity
$5.04▼ $0.84 (−16.76%)
Live1h—
24h▼ 16.8%
7d▼ 16.0%
14d▼ 14.4%
30d▼ 19.2%
1y▼ 37.8%
🏦Market Cap
$970M
Small Cap
📈Revenue Growth (YoY)
-30.4%
Declining
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
18.4x
Expensive
Otter Score
52
Weak
Trading Snapshot
- Day Range
- $4.97 – $5.09
- 52-Week Range
- $5.02 – $21.73
- Volume
- $3.08B
- Avg Volume
- $3.54B
- Shares Outstanding
- 192.4M
- Next Earnings
- Sep 16, 2026
Fundamentals Snapshot
- Annual Revenue
- $60M
- Last Q Revenue
- $14M
- P/E Ratio
- —
- P/S Ratio
- 18.4x
- EPS (TTM)
- $-1.09
- Dividend Yield
- —
Why Investors Own WVE
- ✓High-growth profile — revenue up +34.0% YoY with expanding US Equity exposure.
- ✓Healthy economics — 63% gross margin and 11% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$60M▲ +36.4% YoY
Gross Margin (TTM)
63.1%▲ +3.0% YoY
Operating Income (TTM)
$22M▲ +36.4% YoY
Free Cash Flow (TTM)
$7M▲ +36.4% YoY
About WAVE LIFE SCIENCES LTD
A company profile for WAVE LIFE SCIENCES LTD isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
52/100
Analyst Price Target
ⓘAverage Target
$5.48
▲ +8.8% Upside
High Target$6.04
Low Target$4.17
Based on 11 analysts
Latest News & Updates
🚀
CNBC·2h ago
WAVE LIFE SCIENCES LTD tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Barron’s·5h ago
Analysts lift WVE price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
CNBC·1d ago
WAVE LIFE SCIENCES LTD announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.